How to buy Alliance Pharma (APH) shares

Learn how to easily invest in Alliance Pharma shares.

Alliance Pharma plc (APH) is a publicly traded drug manufacturers-specialty and generic business based in the UK. In the week up to 26 September Alliance Pharma shares plunged 20.35% to a closing position of 59.1p. Over the last 12 months, Alliance Pharma's share price has fallen by 1.92% from 104.2p. Alliance Pharma is listed on the London Stock Exchange (LSE) and employs 250 staff. All prices are listed in pence sterling.

How to buy shares in Alliance Pharma

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: APH in this case.
  5. Research Alliance Pharma shares. The platform should provide the latest information available.
  6. Buy your Alliance Pharma shares. It's that simple.
The whole process can take as little as 15 minutes. You'll need a smartphone or computer, an internet connection, your passport or driving licence and a means of payment.

Fees for buying 100x Alliance Pharma shares with popular platforms

Share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.

Platform Platform fee Min. initial deposit Trading fee estimate
eToro Free Stocks logo £0 $10 £0.00
£102.20 total
Capital at risk
IG Share Dealing logo £0 £250 £8.00
£110.20 total
Capital at risk
Fineco logo £0 No minimum £0.00
£102.20 total
Capital at risk
Hargreaves Lansdown Fund and Share Account logo £0 £1 £11.95
£114.15 total
Capital at risk
Degiro Share Dealing logo £0 £0.01 £1.76
£103.96 total
Capital at risk
Freetrade logo £0 £1 £0.00
£102.20 total
Capital at risk
interactive investor Trading Account logo £9.99 per month No minimum £7.99
£110.19 total
Capital at risk
Halifax Share Dealing Account logo £36 per year £20 £9.50
£111.70 total
Capital at risk

Full comparison of share dealing platforms

Alliance Pharma share price (LSE:APH)

Use our graph to track the performance of APH stocks over time.

Alliance Pharma price performance over time

Historical closes compared with the last close of 102.2p

1 week (2022-09-22) 56.51%
1 month (2022-08-26) 7.58%
3 months (2022-06-29) -9.40%
6 months (2022-03-28) -15.95%
2 years (2020-09-29) 39.05%
3 years (2019-09-27) 39.43%
5 years (2017-09-28) 86.67%

Is it a good time to buy Alliance Pharma stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Promoted
IG bxs hero

Invest in Alliance Pharma shares with IG

  • No commission on US shares
  • More than 13,000 shares to invest in
  • Open your account in minutes

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is Alliance Pharma under- or over-valued?

Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value.

P/E ratio

Alliance Pharma's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 30x. In other words, Alliance Pharma shares trade at around 30x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the FTSE 250 at the end of September 2019 (19.71). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

EBITDA

Alliance Pharma's EBITDA (earnings before interest, taxes, depreciation and amortisation) is £43.3 million.

The EBITDA is a measure of a Alliance Pharma's overall financial performance and is widely used to measure a its profitability.

Alliance Pharma shares at a glance

Information last updated 2021-07-09.
Open103p
High103p
Low100p
Close102.2p
Previous close101.2p
Change1p
Change %0.9881%
Volume387,826
Information last updated 2022-09-25.
52-week range60.7p - 120.8012p
50-day moving average89.506p
200-day moving average105.1885p
Wall St. target price133.8p
PE ratio30.45
Dividend yield1.7p (2.82%)
Earnings per share (TTM)0.02p

Alliance Pharma share dividends

2.8%

Dividend yield: 2.82% of stock value

2.8%

Forward annual dividend yield: 2.82% of stock value

75.8%

Dividend payout ratio: 75.83% of net profits

Alliance Pharma has recently paid out dividends equivalent to 2.82% of its share value annually.

Alliance Pharma has paid out, on average, around 75.83% of recent net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.82% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), shareholders could enjoy a 2.82% return on their shares, in the form of dividend payments. In Alliance Pharma's case, that would currently equate to about 1.7p per share.

Alliance Pharma's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.

The latest dividend was paid out to all shareholders who bought their shares by 22 December 2022 (the "ex-dividend date").

Share price volatility

Over the last 12 months, Alliance Pharma's shares have ranged in value from as little as 60.7p up to 120.8012p. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while Alliance Pharma's is 0.4634. This would suggest that Alliance Pharma's shares are less volatile than average (for this exchange).

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site